Updated dose expansion results of a phase 1/1b study of the bifunctional EGFR/TGFβ inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma Meeting Abstract
| Authors: | Hanna, G. J.; Kaczmar, J.; Zandberg, D. P.; Wong, D. J.; Yilmaz, E.; Sherman, E.; Hernando-Calvo, A.; Sacco, A.; Raben, D.; Odogwu, L.; Bohr, D.; Salazar, R.; Reiners, R.; Chung, C. S. |
| Abstract Title: | Updated dose expansion results of a phase 1/1b study of the bifunctional EGFR/TGFβ inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma |
| Meeting Title: | 2024 Multidisciplinary Head and Neck Cancers Symposium |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 118 |
| Issue: | 5 |
| Meeting Dates: | 2024 Feb 29-Mar 2 |
| Meeting Location: | Phoenix, AZ |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-04-01 |
| Start Page: | e88 |
| Language: | English |
| DOI: | 10.1016/j.ijrobp.2024.01.194 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| DOI/URL: | |
| Notes: | Meeting Abstract: 259 -- Accession Number: 175934859 -- Entry Date: In Process -- Revision Date: 20240313 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Peer Reviewed; USA -- NLM UID: 7603616. -- Source: CINAHL Plus with Full Text |
